PTC Therapeutics director Michael Schmertzler disposes of common shares worth $1.34 million

• PTC Therapeutics director Michael Schmertzler reported sales of 20,000 common shares on Sep. 16-17.
• Sales were priced at USD 66.58 to USD 68.45 per share.
• Indirect holdings were listed at 1,296,594 shares following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PTC Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001288952-26-000012), on September 18, 2026, and is solely responsible for the information contained therein.